MTOR and obesity due to melanocortin 4 receptor deficiency: Of note, hyperactivation of mTOR signaling has been observed in experimental models of endometrial cancer associated with obesity and in a large fraction of endometrial tissues from obese endometrial cancer patients, compared with non-obese patients [61].